Literature DB >> 16920092

Increase in the growth inhibition of bovine pulmonary artery smooth muscle cells by an O-hexanoyl low-molecular-weight heparin derivative.

Hari G Garg1, Charles A Hales, Lunyin Yu, Melissa Butler, Tasneem Islam, Jin Xie, Robert J Linhardt.   

Abstract

Proliferation of pulmonary artery smooth muscle cells (PASMCs) appears to play a significant role in chronic pulmonary hypertension. The proliferation of PASMCs is strongly inhibited by some commercial heparin preparations. Heparin fragments were prepared by periodate treatment, followed by sodium borohydride reduction, to enhance potency. The tributylammonium salt of this fragmented heparin was O-acylated with hexanoic anhydride. Gradient polyacrylamide gel electrophoresis showed that the major heparin fragment contained eight disaccharide units. NMR analysis showed that approximately one hexanoyl group per disaccharide residue was present. The O-hexanoyl heparin fragments were assayed for growth inhibitory effect on bovine PASMCs in culture. This derivative was found to be more effective in growth inhibition of bovine PASMCs in culture than the heparin from which it was derived. In the future, it is envisioned that this or similar derivatives may be an effective treatment for pulmonary hypertension.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16920092      PMCID: PMC4129652          DOI: 10.1016/j.carres.2006.07.014

Source DB:  PubMed          Journal:  Carbohydr Res        ISSN: 0008-6215            Impact factor:   2.104


  20 in total

1.  Terminally alkylated heparin. 2. Potent antiproliferative agent for vascular smooth muscle cells.

Authors:  M Gohda; T Magoshi; S Kato; T Noguchi; S Yasuda; H Nonogi; T Matsuda
Journal:  Biomacromolecules       Date:  2001       Impact factor: 6.988

2.  Effect of fully sulfated glycosaminoglycans on pulmonary artery smooth muscle cell proliferation.

Authors:  H G Garg; P A Joseph; B T Thompson; C A Hales; T Toida; T Imanari; I Capila; R J Linhardt
Journal:  Arch Biochem Biophys       Date:  1999-11-15       Impact factor: 4.013

3.  Further evidence that periodate cleavage of heparin occurs primarily through the antithrombin binding site.

Authors:  Tasneem Islam; Melissa Butler; Sulthan A Sikkander; Toshihiko Toida; Robert J Linhardt
Journal:  Carbohydr Res       Date:  2002-11-19       Impact factor: 2.104

4.  Influence of molecular weight, protein core and charge of native heparin fractions on pulmonary artery smooth muscle cell proliferation.

Authors:  P A Joseph; H G Garg; B T Thompson; X Liu; C A Hales
Journal:  Biochem Biophys Res Commun       Date:  1997-12-08       Impact factor: 3.575

5.  Kinetics of cellular proliferation after arterial injury. II. Inhibition of smooth muscle growth by heparin.

Authors:  A W Clowes; M M Clowes
Journal:  Lab Invest       Date:  1985-06       Impact factor: 5.662

6.  Inhibition of vascular smooth muscle cell migration by heparin-like glycosaminoglycans.

Authors:  R A Majack; A W Clowes
Journal:  J Cell Physiol       Date:  1984-03       Impact factor: 6.384

7.  Impairment of hypoxic pulmonary artery remodeling by heparin in mice.

Authors:  C A Hales; R L Kradin; R D Brandstetter; Y J Zhu
Journal:  Am Rev Respir Dis       Date:  1983-10

8.  Inhibition of rat arterial smooth muscle cell proliferation by heparin. II. In vitro studies.

Authors:  R L Hoover; R Rosenberg; W Haering; M J Karnovsky
Journal:  Circ Res       Date:  1980-10       Impact factor: 17.367

9.  The effect of chronic hypoxia on pulmonary arteries in young rats.

Authors:  B Meyrick; L Reid
Journal:  Exp Lung Res       Date:  1981-11       Impact factor: 2.459

10.  New findings in pulmonary arteries of rats with hypoxia-induced pulmonary hypertension.

Authors:  A Hislop; L Reid
Journal:  Br J Exp Pathol       Date:  1976-10
View more
  5 in total

1.  Effect of carboxyl-reduced heparin on the growth inhibition of bovine pulmonary artery smooth muscle cells.

Authors:  Hari G Garg; Hicham Mrabat; Lunyin Yu; Craig Freeman; Boyangzi Li; Fuming Zhang; Robert J Linhardt; Charles A Hales
Journal:  Carbohydr Res       Date:  2010-03-21       Impact factor: 2.104

2.  Anti-proliferative effects of O-acyl-low-molecular-weight heparin derivatives on bovine pulmonary artery smooth muscle cells.

Authors:  Hari G Garg; Hicham Mrabat; Lunyin Yu; Charles A Hales; Boyangzi Li; Casey N Moore; Fuming Zhang; Robert J Linhardt
Journal:  Glycoconj J       Date:  2011-07-20       Impact factor: 2.916

3.  Growth inhibition of bovine pulmonary artery smooth muscle cells following long-term heparin treatment.

Authors:  Hicham Mrabat; Hari G Garg; Charles A Hales
Journal:  J Cell Physiol       Date:  2009-12       Impact factor: 6.384

4.  Significance of the 2-O-sulfo group of L-iduronic acid residues in heparin on the growth inhibition of bovine pulmonary artery smooth muscle cells.

Authors:  Hari G Garg; Hicham Mrabat; Lunyin Yu; Craig Freeman; Boyangzi Li; Fuming Zhang; Robert J Linhardt; Charles A Hales
Journal:  Carbohydr Res       Date:  2008-07-04       Impact factor: 2.104

5.  Acetylation may strengthen the antitumor activity of low molecular heparin.

Authors:  Ying Liang; Guixin Duan; Yuanyuan Wang; Guowen Wang; Ansheng Wang; Kangwu Wang
Journal:  Transl Cancer Res       Date:  2021-01       Impact factor: 1.241

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.